Tonix shareholders approve reverse stock split authorization and stock plan amendments at annual meeting

Tonix Pharmaceuticals Holding Corp.

Reverse stock split authorized at ratio between 1:2 and 1:250, with 1,764,316 for, 1,203,561 against.
Stock incentive plan amended to increase shares by 1,000,000; 751,420 votes for, 724,627 against.
2025 Employee Stock Purchase Plan approved with 1,134,671 votes for, 249,372 against.
Say-on-pay proposal approved with 1,045,066 votes for; frequency set to every three years.
All 8 director nominees elected; auditor EisnerAmper LLP ratified with 2,812,075 votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.